Lv1
10 积分 2023-12-10 加入
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer
1个月前
已关闭
CASE HISTORY: TRUQAP® (CAPIVASERTIB) WITH FULVESTRANT FOR THE TREATMENT OF HR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER WITH PIK3CA/AKT1/PTEN-ALTERATIONS
2个月前
已完结
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer
2个月前
已关闭
Letter to the Editor – Final Survival Results from the Penelope-B trial investigating palbociclib vs placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy – PENELOPE-B
7个月前
已关闭
皖公网安备34019202002308
